Agios Pharmaceuticals Inc (AGIO)
29.52
+0.09
(+0.31%)
USD |
NASDAQ |
Apr 19, 16:00
29.52
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Gross Profit Margin (Quarterly): 91.75% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 91.75% |
| September 30, 2023 | 91.44% |
| June 30, 2023 | 83.49% |
| March 31, 2023 | 90.12% |
| December 31, 2022 | 90.42% |
| September 30, 2022 | 85.30% |
| June 30, 2022 | 92.21% |
| March 31, 2022 | 59.25% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 |
| Date | Value |
|---|---|
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | 98.49% |
| June 30, 2019 | 98.84% |
| March 31, 2019 | 98.90% |
| December 31, 2018 | 97.66% |
| September 30, 2018 | 95.43% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
59.25%
Minimum
Mar 2022
98.84%
Maximum
Jun 2019
88.13%
Average
90.93%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 80.47% |
| Blueprint Medicines Corp | 99.64% |
| Corcept Therapeutics Inc | 98.61% |
| Ionis Pharmaceuticals Inc | 99.06% |
| Madrigal Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -36.68% |
| Return on Assets | -32.48% |
| Return on Invested Capital | -36.68% |
| Profit Margin (Quarterly) | -1.35K% |
| Operating Margin (Quarterly) | -1.50K% |
| Return on Net Operating Assets | -368.7% |